Outsourced Pharma's Capacity Update January 2025: Cell & Gene Therapy

Forge's Andrew Krajewski showcases Forge's AAV manufacturing capabilities, a flythrough of the Hearth—our custom-designed, 200,000 square foot facility—and more during Outsourced Pharma's Capacity Update. 

Discover how the Hearth, cutting-edge proprietary technologies, and a comprehensive suite of specialized services at Forge set the standard in AAV manufacturing. Designed to support developers at every stage of their journey—from initial discovery through clinical development and ultimately to delivery—Forge’s dedicated team of experts provides tailored solutions to accelerate innovation.

With a focus on precision, scalability, and quality, Forge empowers developers to bring their groundbreaking gene therapies to life, ensuring successful outcomes at every critical milestone.